BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 922 filers reported holding BAXTER INTL INC in Q1 2024. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $175 | -38.8% | 5,212 | -21.9% | 0.11% | -37.9% |
| Q1 2024 | $286 | +57.1% | 6,676 | +42.1% | 0.18% | +46.8% |
| Q4 2023 | $182 | +104.5% | 4,698 | +100.2% | 0.12% | +85.1% |
| Q3 2023 | $89 | -26.4% | 2,347 | -12.0% | 0.07% | -27.2% |
| Q2 2023 | $121 | -5.5% | 2,666 | -15.6% | 0.09% | -17.9% |
| Q1 2023 | $128 | -50.0% | 3,160 | -37.3% | 0.11% | +7.7% |
| Q4 2022 | $256 | -99.8% | 5,038 | +120.6% | 0.10% | -3.7% |
| Q3 2022 | $123,000 | +20.6% | 2,284 | +43.7% | 0.11% | +33.3% |
| Q2 2022 | $102,000 | -41.0% | 1,589 | -28.9% | 0.08% | -29.6% |
| Q1 2022 | $173,000 | +68.0% | 2,235 | +86.7% | 0.12% | -20.1% |
| Q4 2021 | $103,000 | – | 1,197 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soditic Asset Management LLP | 147,620 | $7,951,000 | 9.91% |
| NUANCE INVESTMENTS, LLC | 5,429,702 | $292,444,000 | 6.51% |
| Endurant Capital Management LP | 245,093 | $13,201,000 | 4.30% |
| Veritas Asset Management LLP | 8,589,401 | $462,625,000 | 3.83% |
| GENERATION INVESTMENT MANAGEMENT LLP | 11,876,040 | $639,644,000 | 3.80% |
| Sivik Global Healthcare LLC | 120,000 | $6,463,000 | 3.59% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 480,500 | $25,880,000 | 3.31% |
| Integral Health Asset Management, LLC | 300,000 | $16,158,000 | 3.14% |
| Boothe Investment Group, Inc. | 89,078 | $4,798,000 | 3.11% |
| Glenview Capital Management | 2,257,019 | $121,563,000 | 3.04% |